DeepMed Research

University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Peer Support Group for Adolescent and Young Adult (AYA) Allogeneic Stem Cell Transplant Recipients

Not Applicable

Recruiting

Conditions: Cancer
Leukemia
Stem Cell Transplant

First Posted Date: 2024-11-26

Last Posted Date: 2025-04-24

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 15

Registration Number: NCT06704243

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

VITAMIN D METABOLITES AS BIOMARKERS FOR THE IDENTIFICATION OF KIDNEY INJURY IN CARDIAC SURGERY

Not yet recruiting

Conditions: Acute Kidney Injuries
Chronic Renal Diseases

First Posted Date: 2024-11-14

Last Posted Date: 2024-11-14

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 60

Registration Number: NCT06688994

Locations: 🇨🇦
University Health Network-Toronto General Hospital, Toronto, Ontario, Canada

FES Implementation Pediatrics

Not Applicable

Active, not recruiting

Conditions: Cerebral Palsy (CP)

First Posted Date: 2024-11-14

Last Posted Date: 2024-11-15

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 18

Registration Number: NCT06689007

Locations: 🇨🇦
University of Toronto, Toronto, Ontario, Canada

Toronto Western Hospital (TWH) Waste Audit

Recruiting

Conditions: Audit of Medical Waste Disposal

First Posted Date: 2024-11-08

Last Posted Date: 2025-03-25

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 60

Registration Number: NCT06680284

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol)

Not Applicable

Recruiting

Conditions: Esophageal Cancer
Gastric Cancer
Oligometastatic Disease

First Posted Date: 2024-10-31

Last Posted Date: 2025-05-16

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 72

Registration Number: NCT06668454

Locations: 🇨🇦
Toronto General Hospital, University Health Network, Toronto, Ontario, Canada

Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation

Phase 2

Not yet recruiting

Conditions: Non-Small Cell Lung Cancer
Radiation Induced Lung Injury (RILI)

Interventions: Other: Placebo
Drug: Pentoxifylline
Other: α-Tocopherol

First Posted Date: 2024-10-09

Last Posted Date: 2025-04-09

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 150

Registration Number: NCT06634056

Locations: 🇨🇦
University Health Network - Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Digital Technology for Sleep and Homelessness

Not Applicable

Recruiting

Conditions: Sleep Apnea
Sleep Disorder
Sleep Deprivation
Sleep Disturbance

Interventions: Diagnostic Test: Portable Polysomnography
Device: Treatment
Other: Questionnaires

First Posted Date: 2024-10-01

Last Posted Date: 2024-10-01

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 100

Registration Number: NCT06620601

Locations: 🇨🇦
Dixon Hall, Toronto, Ontario, Canada
🇨🇦
Fred Victor, Toronto, Ontario, Canada

RSV Vaccine in Transplant Recipients

Phase 3

Recruiting

Conditions: Vaccine Response Impaired
Respiratory Syncytial Virus Infections
Immune Suppression

Interventions: Biological: Adjuvant, non-live RSV vaccine

First Posted Date: 2024-09-19

Last Posted Date: 2025-01-27

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 100

Registration Number: NCT06593210

Locations: 🇨🇦
University Health Network, Toronto, Canada

Seronegative Myasthenia Gravis - Efgartigimod IV

Phase 3

Recruiting

Conditions: Efgartigimod
Generalized Myasthenia Gravis

Interventions: Biological: efgartigimod

First Posted Date: 2024-09-09

Last Posted Date: 2024-09-09

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 30

Registration Number: NCT06587867

Locations: 🇨🇦
University Health Network, Division of Neurology, Toronto General Hospital, Toronto, Ontario, Canada

Gemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig in Resectable iCCA

Phase 2

Not yet recruiting

Conditions: Cholangiocarcinoma Resectable

Interventions: Drug: Gemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig

First Posted Date: 2024-08-26

Last Posted Date: 2024-08-26

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 40

Registration Number: NCT06569225

Locations: 🇨🇦
University Health Network, Toronto General Hospital, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy